Provided by Tiger Fintech (Singapore) Pte. Ltd.

Titan Pharmaceuticals

3.75
-0.1000-2.60%
Post-market: 3.750.00000.00%18:37 EDT
Volume:46.34K
Turnover:177.87K
Market Cap:3.43M
PE:-0.72
High:3.95
Open:3.86
Low:3.60
Close:3.85
Loading ...
Dec 17, 2020

Major Issues Report

8-K - Current report
Dec 14, 2020

Correspondence

CORRESP [Cover] - Correspondence
Dec 08, 2020

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Dec 03, 2020

Major Issues Report

8-K - Current report
Dec 01, 2020

Major Issues Report

8-K - Current report
Nov 16, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 09, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 02, 2020

Major Issues Report

8-K - Current report
Oct 28, 2020

Major Issues Report

8-K - Current report
Oct 27, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Oct 26, 2020

Correspondence

CORRESP [Cover] - Correspondence
Oct 26, 2020

Correspondence

CORRESP [Cover] - Correspondence
Oct 26, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Oct 26, 2020

Major Issues Report

8-K - Current report
Oct 19, 2020

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Oct 15, 2020

Major Issues Report

8-K - Current report
Oct 01, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Sep 25, 2020

Major Issues Report

8-K - Current report
Sep 24, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Sep 18, 2020

Major Issues Report

8-K - Current report